Journal
ONCOLOGY LETTERS
Volume 21, Issue 2, Pages -Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/ol.2020.12424
Keywords
breast cancer; invasion; anthrax lethal toxin; MAPK; migration; Rho GTPases
Categories
Funding
- intramural funding at the Lebanese American University
Ask authors/readers for more resources
Breast cancer is a major cause of death in women worldwide, with targeting breast cancer cell metastasis being an important therapeutic approach. The MAPK pathway has been identified as a key player in cellular invasion and migration. In this study, treatment with anthrax lethal toxin (LeTx) inhibited breast cancer cell migration by affecting the activation of RhoA and Cdc42, leading to decreased invasion and increased adhesion.
Breast cancer is the leading cause of cancer-associated death among women worldwide. Targeting breast cancer cell metastasis is an important therapeutic approach. The MAPK pathway is a key cell signaling pathway that plays a pivotal role in cellular invasion and migration. Numerous studies have identified the MAPK pathway as a way to target cell survival and motility. The present study treated MBA-MD-231 breast cancer cells with anthrax lethal toxin (LeTx), a potent MAPK inhibitor that selectively cleaves and inactivates all MEKs, as a potential therapeutic method to inhibit breast cancer cell migration. LeTx has been demonstrated to affect breast cancer cell migration. Cells treated with LeTx showed a significant decrease in motility, as observed using wound healing and random 2D motility assays. Additionally, cells treated with LeTx showed an increase in adhesion, which would explain the decrease in migration. Pull-down assays examining the activation status of the members of the Rho family of GTPases revealed an increase in RhoA activation accompanied by a decrease in Cdc42 activation following LeTx treatment. Finally, LeTx mediated a decrease in invasion using a Boyden chamber assay, which could be a result of the decrease in Cdc42 activation. The present study reported the effect of LeTx treatment on the migration, adhesion and invasion of breast cancer cells, demonstrating that this effect was associated with the dysregulation of the Rho GTPases, RhoA and Cdc42.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available